Most elderly patients with subclinical hypothyroidism do not need to be treated.
Level V
Where this comes from
- Record sourced from PubMed, PMID 40169223.
- Also identified by DOI 10.3949/ccjm.92a.24098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whether subclinical hypothyroidism should be treated in elderly patients (≥ 65 years) is controversial. The authors argue for a personalized, wait-and-see approach rather than universal treatment, pointing out that randomized clinical trials have not shown that levothyroxine treatment makes any difference in terms of hard clinical end points, quality of life, or hypothyroid symptom relief in elderly patients with this condition.
Medical subject headings
- Hypothyroidism
- Thyroxine